The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.
A study showed notable differences in bone mineral density between children on steroids and those not on steroids, with 84% ...
The treatment procedures are required in the case of the severity of the condition. The patient then needs to go for a kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback